DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
D-glucose is an investigational drug.
There have been 31 clinical trials for D-glucose. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2009.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Maryland.
Recent Clinical Trials for D-glucose
|18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules||Canary Foundation||Phase 2|
|18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules||Stanford University||Phase 2|
|Fluorine F 18 Fluorthanatrace PET/CT in Treating Participants With Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer||National Cancer Institute (NCI)||Phase 1|